ImQuest BioSciences, founded in 2004 by Dr. Robert Buckheit, Jr., provides preclinical contract research and development services to help pharmaceutical and biotechnology companies successfully bring new pharmaceuticals and biologics to market.
ImQuest BioSciences offers non-GLP and GLP compliant preclinical discovery, research and development services to define the efficacy, safety, and pharmaceutical property of drug candidates and potential new biologics from initial discovery and screening to IND-enabling studies.
Infectious Disease (Virology/Microbiology) CRO Services
- ViroSENS-antiviral product development services
- MicroSENS-antibacterial and antifungal product development services
- PrevSENS-antimicrobial prevention product development services
- FemSENS-women's health product development services
Toxicology CRO Services
- ToxiSENS-in vitro and ex vivo toxicology services
Product Formulation CRO Services
- PharmaSENS-pharmaceutical product characterization services
Oncology CRO Services
- OncoSENS-anticancer product development services
Additionally, ImQuest Biosciences provides expert consulting, professional and technical services. Our technical services include, flow cytometry, immunoassay development, molecular biology, tissue culture, virus production, enzymology, and analytical services to facilitate and streamline your laboratory operations and discovery initiatives. Our scientists have provided professional services to our clients, collaborators and partners generating over $40 million in NIH funded research and development grants.
Our Expertise and Experience
With over 20 years of experience in preclinical contract research and development services and a significant product development track record, the ImQuest scientific team has extensive expertise in the development of small molecules, natural products, biologics and vaccines for the treatment and prevention of infectious disease, cancer, and inflammatory disease.
Our goal is to help our clients accelerate their research and development efforts leading to the successful development of new products for the prevention and treatment of human disease. We are committed to earning our client's trust through collaboration, unwavering commitment to quality science and consistent and effective communication.